Three-Year Cardiovascular Outcomes of Telmisartan in Patients with Hypertension: An Electronic Health Record-Based Cohort Study.
Yunjin YumJu Hyeon KimHyung Joon JooYong Hyun KimEung Ju KimPublished in: American journal of hypertension (2024)
In real-world practice, telmisartan showed cardiovascular outcomes similar to those of other ARBs in patients with hypertension taking two or more antihypertensive drugs.